AstraZeneca (AZN) Balance Sheet: Assets & Liabilities

AstraZeneca (AZN) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), AstraZeneca reported total assets of $114.07B and total liabilities of $65.36B. Shareholders' equity was $48.67B, up 19.1% from $40.87B a year earlier. Total debt stood at $27.35B against $5.72B in cash and short-term investments, a net debt position of $21.63B. That puts debt-to-equity at 0.56, compared with 0.70 a year earlier.

AstraZeneca Balance Sheet Analysis

Values in billions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for AstraZeneca PLC (AZN) - Annual data in billions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	5.71	5.49	5.84	6.17	6.30	7.79	5.37	4.75	3.32
Short-Term Investments	0.01	0.17	0.12	0.08	0.07	0.16	0.85	0.85	1.23
Cash & Short-Term Investments	5.72	5.53	5.86	6.24	6.37	7.95	6.22	5.59	4.55
Accounts Receivable	10.24	12.97	12.13	9.19	8.76	5.62	4.90	5.68	5.23
Inventory	6.56	5.29	5.42	4.70	8.95	4.00	3.19	2.87	3.02
Other Current Assets	0.08	1.91	1.54	2.46	2.06	1.87	1.26	1.29	0.35
Total Current Assets	28.72	25.83	25.05	22.59	26.14	19.45	15.56	15.43	13.15
Non-Current Assets
Property, Plant & Equipment (Net)	14.70	11.65	10.50	9.45	10.17	8.92	8.06	7.42	7.62
Long-Term Investments	0.30	1.90	1.68	1.14	1.84	1.63	1.51	0.98	1.12
Goodwill	21.24	21.03	20.05	19.82	20.00	11.85	11.29	11.71	11.83
Intangible Assets	37.85	37.18	38.09	39.31	42.39	20.95	20.16	21.96	26.19
Other Non-Current Assets	0.00	6.46	5.75	0.91	0.40	0.40	2.07	0.63	1.27
Total Non-Current Assets	85.35	78.21	76.07	73.89	79.12	47.19	45.81	45.06	50.20
Total Assets	114.07	104.04	101.12	96.48	105.36	66.73	61.38	60.65	63.35
Current Liabilities
Accounts Payable	3.82	22.47	22.37	2.55	2.82	2.35	1.77	1.72	2.29
Short-Term Debt	2.63	2.06	5.60	5.45	1.80	2.39	2.01	1.75	2.25
Current Portion of Long-Term Debt	3.10	2.34	5.13	5.31	1.66	-	-	-	-
Accrued Liabilities	-	16.09	15.85	13.51	12.36	-	-	-	-
Deferred Revenue	0.00	0.13	0.15	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Liabilities	0.77	2.73	2.77	17.39	17.05	14.44	12.97	11.65	10.50
Total Current Liabilities	30.62	27.87	30.54	26.29	22.59	20.31	18.12	16.29	16.38
Non-Current Liabilities
Long-Term Debt	24.72	26.51	22.37	23.69	28.89	17.99	16.22	17.36	15.56
Deferred Tax Liabilities	3.50	3.31	2.84	2.94	6.21	2.92	2.49	3.29	4.00
Other Non-Current Liabilities	5.10	7.68	8.19	6.48	8.36	9.83	9.91	9.59	10.77
Total Non-Current Liabilities	34.74	35.30	31.41	33.13	43.48	30.78	28.66	30.32	30.33
Total Liabilities	65.36	63.16	61.95	59.43	66.08	51.09	46.78	46.61	46.71
Stockholders' Equity
Common Stock	0.39	0.39	0.39	0.39	0.39	0.33	0.33	0.32	0.32
Retained Earnings	10.97	3.16	1.50	-0.57	1.71	5.30	2.81	5.68	8.22
Accumulated Other Comprehensive Income	0.00	1.41	1.46	0.00	0.00	0.00	0.00	0.00	0.00
Additional Paid-in Capital	35.42	35.38	37.25	37.22	37.17	10.00	9.99	6.47	6.42
Minority Interest	0.05	0.09	0.02	0.02	0.02	0.02	1.47	1.58	1.68
Shares Outstanding	1.55	1.55	1.55	1.55	-	-	-	-	-
Total Stockholders' Equity	48.67	40.87	39.17	37.04	39.27	15.62	13.13	12.47	14.96
Total Liabilities & Equity	114.07	104.04	101.12	96.48	105.36	66.73	61.38	60.65	63.35

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About AstraZeneca Balance Sheet

How much debt does AstraZeneca have?

AstraZeneca had total debt of $27.35B as of Dec 31, 2025, against $5.72B in cash and short-term investments. Its debt-to-equity ratio was 0.56. Total debt was $28.56B a year earlier.

What are AstraZeneca's total assets?

AstraZeneca reported total assets of $114.07B as of Dec 31, 2025, up 9.6% from $104.03B a year earlier. Total liabilities were $65.36B.

What is AstraZeneca's shareholders' equity?

AstraZeneca's shareholders' equity was $48.67B as of Dec 31, 2025, or about $31.38 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition